|
Increasing Heart Dose Reduces Overall Survival in Patients Undergoing Postoperative Radiation Therapy for NSCLC
|
September 30, 2021
|
PC3I Authors Michelle Iocolano |
JTO Clinical and Research Reports
|
|
Palliative Care Delivery Systems and Integration With Palliative Care Teams
|
March 29, 2023
|
PC3I Authors Michelle Iocolano |
Seminars in Radiation Oncology
|
|
Utilization and Factors Precluding Receipt of Checkpoint Inhibitor Consolidation for Stage III NSCLC in a Large US Academic Health System
|
April 19, 2023
|
PC3I Authors Michelle Iocolano; Christopher A. D’Avella; Melina Marmarelis; Charu Aggarwal |
Clinical Lung Cancer
|
|
Statin therapy, cardiac events, and survival in patients with non-small cell lung cancer receiving definitive radiotherapy
|
July 29, 2023
|
PC3I Authors Michelle Iocolano |
Radiotherapy and Oncology
|
|
Pneumonitis Rates Before and After Adoption of Immunotherapy Consolidation in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation
|
August 24, 2023
|
PC3I Authors Michelle Iocolano; Charu Aggarwal |
International Journal of Radiation Oncology, Biology, Physics
|
|
Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer
|
August 31, 2023
|
PC3I Authors Michelle Iocolano; Catherine Lai; Charu Aggarwal; Melina Marmarelis |
International Journal of Radiation Oncology, Biology, Physics
|
|
Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression
|
October 9, 2023
|
PC3I Authors Michelle Iocolano; Charu Aggarwal; Melina Marmarelis; Christopher A. D’Avella |
Clinical Lung Cancer
|
|
Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors
|
October 22, 2023
|
PC3I Authors Michelle Iocolano; Charu Aggarwal; Melina Marmarelis |
International Journal of Radiation Oncology, Biology, Physics
|
|
The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC
|
November 26, 2023
|
PC3I Authors Michelle Iocolano; Charu Aggarwal |
Radiotherapy and Oncology
|
|
Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in the durvalumab era
|
January 31, 2024
|
PC3I Authors Michelle Iocolano; Charu Aggarwal |
Cancer
|
